From Forbes: 2024-06-03 04:15:00

Generative AI, like OpenAI’s GPT-4o, is revolutionizing medicine by enhancing diagnostic accuracy, treatment recommendations, and patient monitoring. Despite its impressive capabilities, generative AI adoption is still in its early stages. However, by humanizing AI experiences, companies like OpenAI hope to attract a wide array of users, including older generations with chronic diseases. GPT-4o, with its conversational interface, aims to empower users to take control of their health, potentially preventing hundreds of thousands of premature deaths each year from chronic diseases. In an effort to improve chronic disease management, generative AI tools like GPT-4o can assist patients with round-the-clock monitoring, insights, and advice. With the potential to connect with monitoring devices and provide real-time data, GenAI tools can help patients better diagnose and manage their health problems, reducing complications and improving outcomes for millions of Americans. Efforts are being made to address concerns surrounding AI privacy, security, and misinformation. The transition to a value-based healthcare reimbursement model rewards doctors for preventing chronic diseases, encouraging the use of AI in disease management and prevention. The release of GPT-4o has shattered industry norms by creating human-like AI, introducing ethical risks that must be managed. However, the potential for AI to save thousands of lives each year makes this risk worthwhile.



Read more at Forbes: OpenAI’s Rule-Shattering GPT-4o Update Will Be Lifesaving, Too